TROP2 ADC

DRUG2 trials

Sponsors

Fudan University, Peking Union Medical College

Conditions

Breast CancerPrecision TherapySalivary Gland Carcinoma

Phase 1

Different Targeted Antibody-drug Conjugates For HER2 Ultra-low or No Expression Advanced Breast Cancer（GALAXY）

Active, not recruitingNCT05824325

Fudan UniversityBreast Cancer

Start: 2023-03-14End: 2026-10-10Target: 56Updated: 2023-06-27

Phase 2

Precision Treatment of Recurrent/Metastatic Salivary Gland Carcinoma Guided by Molecular Typing

RecruitingNCT06145308

Peking Union Medical CollegePrecision Therapy, Salivary Gland Carcinoma

Start: 2023-08-15End: 2028-07-10Target: 39Updated: 2026-04-02

Related Papers

Anti-TROP2 ADC ESG401 in a master protocol clinical trial for salivary gland cancer based on molecular typing.

Journal of Clinical Oncology2025-05-28